Alessandro Tavelli, Alessandra Vergori, Antonella Cingolani, Francesca Bai, Anna Maria Azzini, Gabriel Levy Hara, Maria Giulia Caponcello, Matteo Rinaldi, Zaira R Palacios-Baena, Milo Gatti, Gaia Maccarrone, Evelina Tacconelli, Andrea Antinori, Antonella d'Arminio Monforte
{"title":"ORCHESTRA Delphi Consensus: Clinical Management of SARS-CoV-2 Infection in People with HIV.","authors":"Alessandro Tavelli, Alessandra Vergori, Antonella Cingolani, Francesca Bai, Anna Maria Azzini, Gabriel Levy Hara, Maria Giulia Caponcello, Matteo Rinaldi, Zaira R Palacios-Baena, Milo Gatti, Gaia Maccarrone, Evelina Tacconelli, Andrea Antinori, Antonella d'Arminio Monforte","doi":"10.1016/j.cmi.2025.03.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID in PWH.</p><p><strong>Methods: </strong>We performed a study using a 3-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly.</p><p><strong>Results: </strong>Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (I) risk of COVID-19 progression to severe disease among PWH; (II) COVID-19 diagnostics and laboratory procedures; (III) early treatments with antivirals and/or monoclonal antibodies; (IV) use of corticosteroids; (V) COVID-19 preventive strategies.</p><p><strong>Conclusions: </strong>This consensus's study guide infectious diseases physicians in making decisions regarding care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cmi.2025.03.006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID in PWH.
Methods: We performed a study using a 3-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly.
Results: Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (I) risk of COVID-19 progression to severe disease among PWH; (II) COVID-19 diagnostics and laboratory procedures; (III) early treatments with antivirals and/or monoclonal antibodies; (IV) use of corticosteroids; (V) COVID-19 preventive strategies.
Conclusions: This consensus's study guide infectious diseases physicians in making decisions regarding care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.
期刊介绍:
Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.